Загрузка...
Diminished sensitivity of Chronic Lymphocytic Leukemia cells to ABT-737 and ABT-263 due to albumin binding in blood
PURPOSE: Inhibition of the anti-apoptotic BCL2 family is one of the most promising areas of anti-cancer drug development. However, ABT-737, a specific BCL2 inhibitor, is neither orally bioavailable nor metabolically stable. To overcome these problems, the structurally related molecule, ABT-263, was...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921948/ https://ncbi.nlm.nih.gov/pubmed/20601444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-0777 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|